LTRN as of Oct 31 · 11:05 ET
LTRNNasdaqPharmaceutical Preparations

Lantern Pharma Inc. · Brief

Next report

12 days

Nov 12 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±83.4%▲+0.76%×0.01
quarterimplied−85%0+85%realized×
Q2 FY26±83.4%▲+0.76%×0.01
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 12 report · est.

Bull1

39managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

5managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
7 of 18of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

LTRN report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.